PMC:7600245 / 230-482 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":26,"end":40},"obj":"Chemical"},{"id":"T2","span":{"begin":209,"end":219},"obj":"Chemical"},{"id":"T3","span":{"begin":224,"end":237},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_52217"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_41879"}],"text":"the world. Scientists and pharmaceutical companies have promptly responded by advancing potential therapeutics into clinical trials at an exponential rate. Initial encouraging results have been realized using remdesivir and dexamethasone. Yet, the rese"}

{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":11,"end":155},"obj":"Sentence"},{"id":"T6","span":{"begin":156,"end":238},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"the world. Scientists and pharmaceutical companies have promptly responded by advancing potential therapeutics into clinical trials at an exponential rate. Initial encouraging results have been realized using remdesivir and dexamethasone. Yet, the rese"}

{"project":"LitCovid-PubTator","denotations":[{"id":"18","span":{"begin":209,"end":219},"obj":"Chemical"},{"id":"19","span":{"begin":224,"end":237},"obj":"Chemical"}],"attributes":[{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"MESH:C000606551"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D003907"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"the world. Scientists and pharmaceutical companies have promptly responded by advancing potential therapeutics into clinical trials at an exponential rate. Initial encouraging results have been realized using remdesivir and dexamethasone. Yet, the rese"}